Brain Tumor Treatments: Massachusetts
Sponsored By
Please Click On The Above Banner For More Details
Braintumor Website

Search Term: Massachusetts
Please scroll down to see the matching trials.
  (0.8169)   Brain Tumor Treatments: Massachusetts
  (0.7967)   Map
  (0.7742)   Proton Beam
  (0.7742)   PCV For Brain Tumors: Abstracts
  (0.7742)   Chemosensitivity For Oligodendrogliomas
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   RSR-13
  (0.7742)   Doctor / Hospital Address Book
  (0.7742)   Brain Tumor Activism
  (0.7742)   Letter Writing Wizard
  (0.7742)   Brain Tumor Activism
  (0.7742)   Thoughts on Combinations Of Treatments For Brain Tumors
  (0.7742)   Untitled Document
  (0.7742)   Brain Tumor Survivor Stories
  (0.7742)   Brain Tumor Trials And Treatments
  (0.7742)   Brain Tumor Survivor Stories
  (0.7742)   Brain Tumor Trials And Treatments
  (0.7742)   RSR-13
  (0.7742)   RSR-13
  (0.7742)   Brain Tumor Trials And Treatments
  (0.7742)   Brain Tumor Trials And Treatments

Sorry - There were no pages found that contain that search phrase.



  Showing Treatment 1 to 25 of 61 Next 25 Location Last Updated
Details Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor Boston, MA 09/06/2009
Details Phase 2 Study of Azixa (MPC-6827) for the Treatment of Patients With Recurrent Glioblastoma Multiforme Burlington, MA USA 08/11/2009
Details Phase 2 Study of Azixa (MPC-6827) for the Treatment of Patients With Recurrent Glioblastoma Multiforme Boston, MA USA 08/11/2009
Details Phase 2 Study of Azixa (MPC-6827) for the Treatment of Patients With Recurrent Glioblastoma Multiforme Worcester, MA USA 08/11/2009
Details A Feasibility Assessment and a Phase I/II Trial of MLN518 (Tandutinib) for Treatment of Patients with Recurrent Glioblastoma Boston, MA USA 04/21/2009
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) Boston, MA 01/31/2009
Details Bevacizumab (Avastin) and Irinotecan (CPT-11) in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma Boston, MA USA 11/08/2008
Details Phase I Trial of Aflibercept (VEGF Trap)with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Gliomas Boston, MA USA 10/27/2008
Details A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma Boston, MA USA 10/09/2008
Details CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan Boston, MA USA 10/09/2008
Details Phase 2, 2-Part, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of CT-322 Monotherapy and Combination Therapy With Irinotecan in Patients With Recurrent Glioblastoma Multiforme Boston, MA USA 04/27/2008
Details Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma Boston, MA USA 04/15/2008
Details A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas Boston, MA 04/15/2008
Details NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 Boston, MA USA 03/01/2008
Details Gliogene: Brain Tumor Linkage Study Boston, MA USA 01/17/2008
Details NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma Boston, MA 10/03/2007
Details Phase I/II Study of Fractionated CyberKnife Stereotactic Radiosurgery for High Grade Gliomas in Elderly Patients With Poor Performance Status Boston, MA USA 08/26/2007
Details Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Boston, MA USA 08/19/2007
Details Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Boston, MA USA 08/19/2007
Details Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Boston, MA 08/19/2007
Details A Pilot Multicenter Phase I/II Trial of RAD001 in Patients With Recurrent Glioblastoma Multiforme Boston, MA 08/19/2007
Details Brain Mapping for Brain Tumors Boston, MA USA 08/18/2007
Details Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma Boston, MA 08/04/2007
Details A Phase I Imaging and Safety Study of Intravenous 131-I-TM-601 Labelled Chlorotoxin In Patients with Recurrent or Refractory Somatic and/or Cereberal Metastatic Solid Tumors Cambridge, MA USA 06/04/2007
Details Phase I/II Study of Intravenous Infusion of Tetra-o-Methyl Nordihydroguaiaretic Acid (EM-1421) in Subjects With Recurrent High Grade Glioma Boston, MA USA 05/01/2007


Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Chat | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book

IF YOU ARE USING A SCREEN READER, CLICK HERE
[Click HERE to open a Printer Friendly Version Of This Page!]

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By
World Wide Websites